Zhang Jing-Jing, Ma Xin-Xin, Hao Li, Liu Li-Jun, Lv Ji-Cheng, Zhang Hong
Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; and Department of Nephrology, Second Hospital of Anhui Medical University, Hefei, China.
Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; and.
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1964-78. doi: 10.2215/CJN.09250914. Epub 2015 Oct 20.
We undertook a systematic review and meta-analysis of published cohort studies and case-control studies to estimate (1) the risk of pregnancy complications among patients with CKD versus those without CKD and (2) the risk of CKD progression among pregnant patients versus nonpregnant controls with CKD.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We searched electronic databases for studies published between 1946 and 2014, and we reviewed articles using validity criteria. Random-effects analytical methods were used.
Twenty-three studies (14 with data for adverse pregnancy outcomes and 9 for renal outcomes) with 506,340 pregnancies were included. Pregnancy with CKD had greater odds of preeclampsia (odds ratio [OR], 10.36; 95% confidence interval [95% CI], 6.28 to 17.09), premature delivery (OR, 5.72; 95% CI, 3.26 to 10.03), small for gestational age/low birth weight (OR, 4.85; 95% CI, 3.03 to 7.76), cesarean section (OR, 2.67; 95% CI, 2.01 to 3.54), and failure of pregnancy (OR, 1.80; 95% CI, 1.03 to 3.13). Subgroup analysis showed that odds of preeclampsia (P<0.01) and premature delivery (P<0.01) were higher in women with nondiabetic nephropathy compared with diabetic nephropathy, and the odds of preeclampsia (P=0.01) and premature delivery (P<0.01) were higher in women with macroproteinuria compared with microproteinuria. The median for follow-up time for renal events was 5 years (interquartile range, 5-14.7 years). There were no significant differences in the occurrence of renal events between CKD pregnant women and those without pregnancy (OR, 0.96; 95% CI, 0.69 to 1.35). Subgroup analysis showed that publication year, sample size, follow-up years, type of primary disease, CKD classification, level of serum creatinine at baseline, proteinuria, and level of systolic BP did not modify the renal outcomes.
The risks of adverse maternal and fetal outcomes in pregnancy are higher for women with CKD versus pregnant women without CKD. However, pregnancy was not a risk factor for progression of renal disease in women with CKD before pregnancy.
我们对已发表的队列研究和病例对照研究进行了系统评价和荟萃分析,以评估:(1)慢性肾脏病(CKD)患者与非CKD患者发生妊娠并发症的风险;(2)妊娠CKD患者与非妊娠CKD对照者发生CKD进展的风险。
设计、地点、参与者及测量方法:我们检索了电子数据库中1946年至2014年间发表的研究,并根据有效性标准对文章进行了综述。采用随机效应分析方法。
纳入了23项研究(14项有不良妊娠结局数据,9项有肾脏结局数据),涉及506,340例妊娠。患有CKD的孕妇发生子痫前期的几率更高(优势比[OR],10.36;95%置信区间[95%CI],6.28至17.09)、早产(OR,5.72;95%CI,3.26至10.03)、小于胎龄儿/低出生体重(OR,4.85;95%CI,3.03至7.76)、剖宫产(OR,2.67;95%CI,2.01至3.54)及妊娠失败(OR,1.80;95%CI,1.03至3.13)。亚组分析显示,与糖尿病肾病女性相比,非糖尿病肾病女性发生子痫前期(P<0.01)和早产(P<0.01)的几率更高;与微量蛋白尿女性相比,大量蛋白尿女性发生子痫前期(P=0.01)和早产(P<0.01)的几率更高。肾脏事件的中位随访时间为5年(四分位间距,5 - 14.7年)。CKD孕妇与未怀孕者之间肾脏事件的发生率无显著差异(OR,0.96;95%CI,0.69至1.35)。亚组分析显示,发表年份、样本量、随访年限、原发性疾病类型、CKD分类、基线血清肌酐水平、蛋白尿及收缩压水平均未改变肾脏结局。
与非CKD孕妇相比,CKD孕妇发生不良母婴结局的风险更高。然而,妊娠并非妊娠前患有CKD女性肾脏疾病进展的危险因素。